Role of Matra basti with and without Shashtika shali pinda Sweda in the cerebral palsy in children.

A NON-RANDOMIZED PARALLEL GROUP CLINICAL TRIAL TO EVALUATE THE ROLE OF MATRA BASTI WITH AND WITHOUT SHASHTIKA SHALI PINDA SWEDA IN THE MANAGEMENT OF CEREBRAL PALSY IN CHILDREN - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101045

Enrollment

Registered

2026-01-14

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F99- Mental disorder, not otherwise specified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 1-5 year of either sex. 2. children physically and mentally handicaped due to to CP. 3. Children with delayed milestones, growth and development. 4. Medically stable and able to participate in assessment or interventions.

Exclusion criteria

Exclusion criteria: 1. Children below 1 year and above 5 year of age. 2. Participants with co-existing neurological disorders & muscular dystrophy. 3. Children with metabolic disorder like juvenile DM. 4. Severe cognitive impairments or behavioral issues. 5. History of uncontrolled seizures or other acute medical conditions like , sever infection, systemic illness like TB. Gastrointestinal disease that could interfere with participation Children with metabolic disorder like juvenile DM. 4. Severe cognitive impairments or behavioral issues. 5. History of uncontrolled seizures or other acute medical conditions like , sever infection, systemic illness like TB. Gastrointestinal disease that could interfare with participation.

Design outcomes

Primary

Measure	Time frame
Improvement in quality of life of children. 2. Improvement in Speech/Language communication, Sociability, Sensory/Cognitive Awareness, Health awareness.Timepoint: After completing 30 days of clinical trial.	—

Secondary

Measure	Time frame
To evaluate the role of Matra Basti with and without Shashtika Shali Pinda SwedaTimepoint: After completing 105 days of clinical trial	—

Countries

India

Contacts

Public ContactDr Ramesh kumar gautam

State Ayurvedic college and hospital Lucknow

gautamramesh09@gmail.com9450361310

Outcome results